Speaker illustration

Doctor Anna Humphreys

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

ACEi/ARB treatment in patients with myocardial infarction and preserved left ventricular ejection fraction does not confer a benefit: a target trial emulation

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pharmacotherapy in coronary artery disease (1)

Thumbnail